NCT02042326: Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations
- State
- Under way
- Phase
- Phase 2
- People
- 50 planned
- Started
- 12 Sep 2014
- Primary completion
- Sep 2027
- Arms
- Sirolimus treatment
- Results
- None posted
- 22 Jan 2014: Trial registered
- 12 Sep 2014: Trial started